Xcell Therapeutics Inc. (KOSDAQ:373110)
1,368.00
-69.00 (-4.80%)
Apr 2, 2026, 3:30 PM KST
-62.11% (1Y)
| Market Cap | 24.85B -45.9% |
| Revenue (ttm) | 1.95B -30.0% |
| Net Income | -10.93B |
| EPS | -938.00 |
| Shares Out | 17.29M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 60,238 |
| Average Volume | 97,235 |
| Open | 1,455.00 |
| Previous Close | 1,437.00 |
| Day's Range | 1,367.00 - 1,455.00 |
| 52-Week Range | 1,301.00 - 4,530.00 |
| Beta | n/a |
| RSI | 48.09 |
| Earnings Date | Apr 6, 2026 |